CATHY WOOD: Open Payments
NPI 1871939389 · MULLICA HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,046 in 32 payments from 10 companies in 2025. Trend: 2023 $1,251 · 2024 $1,588 · 2025 $1,046
Food & beverage: $1,026Education: $20
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $293 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $204 |
| AstraZeneca Pharmaceuticals LP | 3 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Amgen Inc. | 3 | $47 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Hologic Sales and Service, LLC | 1 | $17 |
Products named: JARDIANCE, CAMZYOS, LOKELMA, Kerendia, LifeVest, LEQVIO, FARXIGA, REPATHA.
Industry payments across NJ — which companies pay providers there.
